Our portfolio

PacingCure

PacingCure is pioneering gene therapy solutions to cure heart conditions that results in pacing issues. The company focuses on developing biological pacemakers for patients who cannot use conventional electronic pacemaker devices. Their research explores various transgenes and delivery systems to modulate heart pacing. PacingCure is dedicated to advancing cardiac care through innovative gene therapy.

Industry: Cardiology, Gene Therapy, Therapeutics

Want to get in contact about PacingCure?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Developing novel treatments for Parkinson’s disease and dopamine disorders.
A citizen engagement platform for real-time polling and response aggregation.
Personalized e-health recovery plans for post-surgery rehabilitation.
Combining quantum computing and classical simulations for material science.
Developing novel treatments for Parkinson’s disease and dopamine disorders.
A citizen engagement platform for real-time polling and response aggregation.
Personalized e-health recovery plans for post-surgery rehabilitation.
Combining quantum computing and classical simulations for material science.